{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T03:52:01Z","timestamp":1772164321583,"version":"3.50.1"},"reference-count":47,"publisher":"American Association for Cancer Research (AACR)","issue":"2","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,1,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The retinoblastoma (RB) tumor suppressor pathway is likely important in primitive neuroectodermal tumors (PNET) of the brain. In fact, 10% to 15% of children born with RB mutations develop brain PNETs, commonly in the pineal gland. Cyclin D1, which in association with cyclin-dependent kinase (Cdk) 4 and Cdk6 phosphorylates and inactivates the RB protein, is expressed in 40% of sporadic medulloblastoma, a PNET of the cerebellum. To understand tumorigenic events cooperating with RB pathway disruption in brain PNET, we generated a transgenic mouse where cyclin D1 was expressed in pineal cells. Cyclin D1 enhanced pinealocyte proliferation, causing pineal gland enlargement. However, proliferation ceased beyond 2 weeks of age with reversal of Cdk4-mediated Rb phosphorylation despite continued expression of the transgene, and the pineal cells showed heterochromatin foci suggestive of a senescent-like state. In the absence of the p53 tumor suppressor, cell proliferation continued, resulting in pineal PNET that limited mouse survival to \u223c4 months. Interestingly, the Cdk inhibitor p18Ink4c was induced in the transgenic pineal glands independently of p53, and transgenic mice that lacked Ink4c developed invasive PNET, although at an older age than those lacking p53. Analogous to our mouse model, we found that children with heritable RB often had asymptomatic pineal gland enlargement that only rarely progressed to PNET. Our finding that the Cdk4 inhibitor p18Ink4c is a tumor suppressor in cyclin D1\u2013driven PNET suggests that pharmacologic interventions to inhibit Cdk4 activity may be a useful chemoprevention or therapeutic strategy in cancer driven by primary RB pathway disruption. [Cancer Res 2009;69(2):440\u20138]<\/jats:p>","DOI":"10.1158\/0008-5472.can-08-1892","type":"journal-article","created":{"date-parts":[[2009,1,15]],"date-time":"2009-01-15T03:52:56Z","timestamp":1231991576000},"page":"440-448","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["<i>p18Ink4c<\/i>\n                    and\n                    <i>p53<\/i>\n                    Act as Tumor Suppressors in\n                    <i>Cyclin D1<\/i>\n                    \u2013Driven Primitive Neuroectodermal Tumor"],"prefix":"10.1158","volume":"69","author":[{"given":"Raya","family":"Saab","sequence":"first","affiliation":[{"name":"1Children's Cancer Center of Lebanon, American University of Beirut Medical Center, Beirut, Lebanon; Departments of"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Rodriguez-Galindo","sequence":"additional","affiliation":[{"name":"2Oncology,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly","family":"Matmati","sequence":"additional","affiliation":[{"name":"3Radiological Sciences,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerold E.","family":"Rehg","sequence":"additional","affiliation":[{"name":"4Pathology, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shannon H.","family":"Baumer","sequence":"additional","affiliation":[{"name":"7Department of Pediatrics, Section of Hematology-Oncology, University of Chicago, Chicago, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph D.","family":"Khoury","sequence":"additional","affiliation":[{"name":"4Pathology, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Billups","sequence":"additional","affiliation":[{"name":"5Biostatistics and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geoffrey","family":"Neale","sequence":"additional","affiliation":[{"name":"6Hartwell Center for Bioinformatics and Biotechnology, St. Jude Children's Research Hospital, Memphis, Tennessee; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen J.","family":"Helton","sequence":"additional","affiliation":[{"name":"3Radiological Sciences,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen X.","family":"Skapek","sequence":"additional","affiliation":[{"name":"7Department of Pediatrics, Section of Hematology-Oncology, University of Chicago, Chicago, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1086","published-online":{"date-parts":[[2009,1,15]]},"reference":[{"key":"2022061701352649000_B1","doi-asserted-by":"crossref","unstructured":"Cobrinik D. Pocket proteins and cell cycle control. Oncogene\u20082005; 24: 2796\u2013809.","DOI":"10.1038\/sj.onc.1208619"},{"key":"2022061701352649000_B2","doi-asserted-by":"crossref","unstructured":"Diehl JA. Cycling to cancer with cyclin D1. Cancer Biol Ther\u20082002; 1: 226\u201331.","DOI":"10.4161\/cbt.72"},{"key":"2022061701352649000_B3","doi-asserted-by":"crossref","unstructured":"Arnold A, Papanikolaou A. Cyclin D1 in breast cancer pathogenesis. J Clin Oncol\u20082005; 23: 4215\u201324.","DOI":"10.1200\/JCO.2005.05.064"},{"key":"2022061701352649000_B4","doi-asserted-by":"crossref","unstructured":"Lovec H, Grzeschiczek A, Kowalski M-B, Moroy T. Cyclin D1\/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma. EMBO J\u20081994; 13: 3487\u201395.","DOI":"10.1002\/j.1460-2075.1994.tb06655.x"},{"key":"2022061701352649000_B5","doi-asserted-by":"crossref","unstructured":"Bodrug SE, Warner BJ, Bath ML, Lindeman GJ, Harris AW, Adams JM. Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene. EMBO J\u20081994; 13: 2124\u201330.","DOI":"10.1002\/j.1460-2075.1994.tb06488.x"},{"key":"2022061701352649000_B6","doi-asserted-by":"crossref","unstructured":"Wang TC, Cardiff RD, Zukerberg L, Lees E, Arnold A, Schmidt EV. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature\u20081994; 369: 669\u201371.","DOI":"10.1038\/369669a0"},{"key":"2022061701352649000_B7","unstructured":"Deane NG, Parker MA, Aramadla R, et al. Hepatocellular carcinoma results from chronic cyclin D1 overexpression in transgenic mice. Cancer Res\u20082001; 61: 5389\u201395."},{"key":"2022061701352649000_B8","doi-asserted-by":"crossref","unstructured":"Becker LE, Hinton D. Primitive neuroectodermal tumors of the central nervous system. Hum Pathol\u20081983; 14: 538\u201350.","DOI":"10.1016\/S0046-8177(83)80006-9"},{"key":"2022061701352649000_B9","doi-asserted-by":"crossref","unstructured":"Neben K, Korshunov A, Benner A, et al. Microarray-based screening for molecular markers in medulloblastoma revealed STK15 as independent predictor for survival. Cancer Res\u20082004; 64: 3103\u201311.","DOI":"10.1158\/0008-5472.CAN-03-3968"},{"key":"2022061701352649000_B10","doi-asserted-by":"crossref","unstructured":"Gilbertson RJ. Medulloblastoma: signaling a change in treatment. Lancet Oncol\u20082004; 5: 209\u201318.","DOI":"10.1016\/S1470-2045(04)01424-X"},{"key":"2022061701352649000_B11","doi-asserted-by":"crossref","unstructured":"Oliver TG, Grasfeder LL, Carrol AL, et al. Transcriptional profiling of the Sonic hedgehog response: a critical role for N-myc in proliferation of neuronal precursors. Proc Natl Acad Sci U S A\u20082003; 100: 7331\u20136.","DOI":"10.1073\/pnas.0832317100"},{"key":"2022061701352649000_B12","doi-asserted-by":"crossref","unstructured":"Pogoriler J, Millen K, Utset M, Du W. Loss of cyclin D1 impairs cerebellar development and suppresses medulloblastoma formation. Development\u20082006; 133: 3929\u201337.","DOI":"10.1242\/dev.02556"},{"key":"2022061701352649000_B13","doi-asserted-by":"crossref","unstructured":"Liou GI, Geng L, Al-Ubaidi MR, et al. Tissue-specific expression in transgenic mice directed by the 5\u2032-flanking sequences of the human gene encoding interphotoreceptor retinoid-binding protein. J Biol Chem\u20081990; 265: 8373\u20136.","DOI":"10.1016\/S0021-9258(19)38895-7"},{"key":"2022061701352649000_B14","doi-asserted-by":"crossref","unstructured":"Skapek SX, Lin S-CJ, Jablonski MM, et al. Persistent expression of cyclin D1 disrupts normal photoreceptor differentiation and retina development. Oncogene\u20082001; 20: 6742\u201351.","DOI":"10.1038\/sj.onc.1204876"},{"key":"2022061701352649000_B15","doi-asserted-by":"crossref","unstructured":"Silva RL, Thornton JD, Martin AC, et al. Arf-dependent regulation of Pdgf signaling in perivascular cells in the developing mouse eye. EMBO J\u20082005; 24: 2803\u201314.","DOI":"10.1038\/sj.emboj.7600751"},{"key":"2022061701352649000_B16","doi-asserted-by":"crossref","unstructured":"Latres E, Malumbres M, Sotillo R, et al. Limited overlapping roles of P15(INK4b) and P18(INK4c) cell cycle inhibitors in proliferation and tumorigenesis. EMBO J\u20082000; 19: 3496\u2013506.","DOI":"10.1093\/emboj\/19.13.3496"},{"key":"2022061701352649000_B17","doi-asserted-by":"crossref","unstructured":"Chan PKS, Chan DPC, To K-F, Cheung JLK, Cheng AF. Evaluation of extraction methods from paraffin wax embedded tissues for PCR amplification of human and viral DNA. J Clin Pathol\u20082001; 54: 401\u20133.","DOI":"10.1136\/jcp.54.5.401"},{"key":"2022061701352649000_B18","doi-asserted-by":"crossref","unstructured":"Fung K-M, Trojanowski JQ. Animal models of medulloblastomas and related primitive neuroectodermal tumor. A review. J Neuropathol Exp Neurol\u20081995; 54: 285\u201396.","DOI":"10.1097\/00005072-199505000-00001"},{"key":"2022061701352649000_B19","doi-asserted-by":"crossref","unstructured":"McKeller RN, Fowler JL, Cunningham JJ, et al. The Arf tumor suppressor gene promotes hyaloid vascular regression during mouse eye development. Proc Natl Acad Sci U S A\u20082002; 99: 3848\u201353.","DOI":"10.1073\/pnas.052484199"},{"key":"2022061701352649000_B20","unstructured":"Sumida M, Barkovich AJ, Newton TH. Development of the pineal gland: measurement with MR. AJNR Am J Neuroradiol\u20081996; 17: 233\u20136."},{"key":"2022061701352649000_B21","doi-asserted-by":"crossref","unstructured":"Hinds PW, Mittnacht S, Dulic V, Arnold A, Reed SI, Weinberg RA. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell\u20081992; 70: 993\u20131006.","DOI":"10.1016\/0092-8674(92)90249-C"},{"key":"2022061701352649000_B22","doi-asserted-by":"crossref","unstructured":"Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev\u20081999; 13: 1501\u201312.","DOI":"10.1101\/gad.13.12.1501"},{"key":"2022061701352649000_B23","doi-asserted-by":"crossref","unstructured":"Kitagawa M, Higashi H, Jung HK, et al. The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A\/E-Cdk2. EMBO J\u20081996; 15: 7060\u20139.","DOI":"10.1002\/j.1460-2075.1996.tb01097.x"},{"key":"2022061701352649000_B24","doi-asserted-by":"crossref","unstructured":"Connell-Crowley L, Harper JW, Goodrich DW. Cyclin D1\/Cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by site-specific phosphorylation. Mol Biol Cell\u20081997; 8: 287\u2013301.","DOI":"10.1091\/mbc.8.2.287"},{"key":"2022061701352649000_B25","doi-asserted-by":"crossref","unstructured":"Campisi J. Cellular senescence as a tumor-suppressor mechanism. Trends Cell Biol\u20082001; 11: S27\u201331.","DOI":"10.1016\/S0962-8924(01)82148-6"},{"key":"2022061701352649000_B26","doi-asserted-by":"crossref","unstructured":"Shay JW, Roninson IB. Hallmarks of senescence in carcinogenesis and cancer therapy. Oncogene\u20082004; 2004: 2919\u201333.","DOI":"10.1038\/sj.onc.1207518"},{"key":"2022061701352649000_B27","doi-asserted-by":"crossref","unstructured":"Mooi WJ, Peeper DS. Oncogene-induced cell senescence\u2014halting on the road to cancer. N Engl J Med\u20082006; 355: 1037\u201346.","DOI":"10.1056\/NEJMra062285"},{"key":"2022061701352649000_B28","doi-asserted-by":"crossref","unstructured":"Narita M, Nunez S, Heard E, et al. Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell\u20082003; 113: 703\u201316.","DOI":"10.1016\/S0092-8674(03)00401-X"},{"key":"2022061701352649000_B29","doi-asserted-by":"crossref","unstructured":"Ferbeyre G, de SE, Lin AW, et al. Oncogenic ras and p53 cooperate to induce cellular senescence. Mol Cell Biol\u20082002; 22: 3497\u2013508.","DOI":"10.1128\/MCB.22.10.3497-3508.2002"},{"key":"2022061701352649000_B30","doi-asserted-by":"crossref","unstructured":"Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell\u20081997; 88: 593\u2013602.","DOI":"10.1016\/S0092-8674(00)81902-9"},{"key":"2022061701352649000_B31","doi-asserted-by":"crossref","unstructured":"Donehower LA, Harvey M, Slagle BL, et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature\u20081992; 356: 215\u201321.","DOI":"10.1038\/356215a0"},{"key":"2022061701352649000_B32","doi-asserted-by":"crossref","unstructured":"Williams BO, Remington L, Albert DM, Mukai S, Bronson RT, Jacks T. Cooperative tumorigenic effects of germline mutations in Rb and p53. Nat Genet\u20081994; 7: 480\u20134.","DOI":"10.1038\/ng0894-480"},{"key":"2022061701352649000_B33","doi-asserted-by":"crossref","unstructured":"Campisi J. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell\u20082005; 120: 513\u201322.","DOI":"10.1016\/j.cell.2005.02.003"},{"key":"2022061701352649000_B34","doi-asserted-by":"crossref","unstructured":"Thornton JD, Silva RLA, Martin AC, Skapek SX. The Arf tumor suppressor regulates platelet-derived growth factor receptor \u03b2 signaling: a new view through the eyes of Arf\u2212\/\u2212 mice. Cell Cycle\u20082005; 4: 1316\u20139.","DOI":"10.4161\/cc.4.10.2109"},{"key":"2022061701352649000_B35","doi-asserted-by":"crossref","unstructured":"Uziel T, Zindy F, Xie S, et al. The tumor suppressors Ink4c and p53 collaborate independently with Patched to suppress medulloblastoma formation. Genes Dev\u20082005; 19: 2656\u201367.","DOI":"10.1101\/gad.1368605"},{"key":"2022061701352649000_B36","doi-asserted-by":"crossref","unstructured":"Blach LE, McCormick B, Abramson DH, Ellsworth RM. Trilateral retinoblastoma\u2014incidence and outcome: a decade of experience. Int J Radiat Oncol Biol Phys\u20081994; 29: 729\u201333.","DOI":"10.1016\/0360-3016(94)90560-6"},{"key":"2022061701352649000_B37","doi-asserted-by":"crossref","unstructured":"Kivela T. Trilateral retinoblastoma: a meta-analysis of hereditary retinoblastoma associated with primary ectopic intracranial retinoblastoma. J Clin Oncol\u20081999; 17: 1829\u201337.","DOI":"10.1200\/JCO.1999.17.6.1829"},{"key":"2022061701352649000_B38","unstructured":"Cordon-Cardo C, Latres E, Drobnjak M, Oliva MR, Brennan MF, Levine AJ. Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas. Cancer Res\u20081994; 54: 794\u20139."},{"key":"2022061701352649000_B39","doi-asserted-by":"crossref","unstructured":"Soussi T, Beroud C. Assessing TP53 status in human tumours to evaluate clinical outcome. Nat Rev Cancer\u20082001; 1: 233\u201340.","DOI":"10.1038\/35106009"},{"key":"2022061701352649000_B40","doi-asserted-by":"crossref","unstructured":"Ramsey MR, Krishnamurthy J, Pei X-H, et al. Expression of p16Ink4a compensates for p18Ink4c loss in cyclin-dependent kinase 4\/6-dependent tumors and tissues. Cancer Res\u20082007; 67: 4732\u201341.","DOI":"10.1158\/0008-5472.CAN-06-3437"},{"key":"2022061701352649000_B41","unstructured":"Zindy F, Nilsson LM, Nguyen L, et al. Hemangiosarcomas, medulloblastomas, and other tumors in Ink4c\/p53-null mice. Cancer Res\u20082003; 63: 5420\u20137."},{"key":"2022061701352649000_B42","doi-asserted-by":"crossref","unstructured":"Zindy F, Uziel T, Ayrault O, et al. Genetic alterations in mouse medulloblastomas and generation of tumors de novo from primary cerebellar granule neuron precursors. Cancer Res\u20082007; 67: 2676\u201384.","DOI":"10.1158\/0008-5472.CAN-06-3418"},{"key":"2022061701352649000_B43","doi-asserted-by":"crossref","unstructured":"Solomon DA, Kim J-S, Jenkins S, et al. Identification of p18INK4c as a tumor suppressor gene in glioblastoma multiforme. Cancer Res\u20082008; 68: 2564\u20139.","DOI":"10.1158\/0008-5472.CAN-07-6388"},{"key":"2022061701352649000_B44","doi-asserted-by":"crossref","unstructured":"Sherr CJ. Principles of tumor suppression. Cell\u20082004; 116: 235\u201346.","DOI":"10.1016\/S0092-8674(03)01075-4"},{"key":"2022061701352649000_B45","doi-asserted-by":"crossref","unstructured":"Tolbert D, Lu X, Yin C, Tantama M, Van Dyke T. p19Arf is dispensable for oncogenic stress-induced p53-mediated apoptosis and tumor suppression in vivo. Mol Cell Biol\u20082002; 22: 370\u20137.","DOI":"10.1128\/MCB.22.1.370-377.2002"},{"key":"2022061701352649000_B46","doi-asserted-by":"crossref","unstructured":"Halazonetis TD, Gorgoulis VG, Bartek J. An oncogene-induced DNA damage model for cancer development. Science\u20082008; 319: 1352\u20135.","DOI":"10.1126\/science.1140735"},{"key":"2022061701352649000_B47","doi-asserted-by":"crossref","unstructured":"Kenney AM, Rowitch DH. Sonic hedgehog promotes G1 cyclin expression and sustained cell cycle progression in mammalian neuronal precursors. Mol Cell Biol\u20082000; 20: 9055\u201367.","DOI":"10.1128\/MCB.20.23.9055-9067.2000"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/69\/2\/440\/2614626\/440.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/69\/2\/440\/2614626\/440.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T03:46:07Z","timestamp":1655437567000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/69\/2\/440\/549991\/p18Ink4c-and-p53-Act-as-Tumor-Suppressors-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,15]]},"references-count":47,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2009,1,15]]},"published-print":{"date-parts":[[2009,1,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-08-1892","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.22378215","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6498840","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6498840.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22378215.v1","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,15]]}}}